REGISTERED
on 01 Nov 2022
Last Applicant/ Owned by
2031 US Highway 130
Monmouth Junction
NJ
08852
Serial Number
88672961 filed on 29th Oct 2019
Registration Number
6890002 registered on 01st Nov 2022
Correspondent Address
Cathy A. Kodroff
Filing Basis
1. intent to use
2. use application currently
Disclaimer
NO DATA
NEXICLON
Pharmaceutical preparations, namely, pharmaceutical preparations containing the drug clonidine, intended for the treatment of various indications, including, hypertension, Tourette's Syndrome, Attention Deficient Hyperactivity Disorder and Autism
Classification Information
Class [005]
Pharmaceutical Products
Pharmaceutical preparations, namely, pharmaceutical preparations containing the drug clonidine, intended for the treatment of various indications, including, hypertension, Tourette's Syndrome, Attention Deficient Hyperactivity Disorder and Autism
First Use Date in General
31st Jul 2021
First Use Date in Commerce
31st Jul 2021
Mark Details
Serial Number
No 88672961
Mark Type
No Service/Collective Mark
Attorney Docket Number
No TRIS-NEXICLO
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 01st Nov 2022 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| 01st Nov 2022 | REGISTERED-PRINCIPAL REGISTER |
| 30th Sep 2022 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
| 29th Sep 2022 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| 29th Sep 2022 | STATEMENT OF USE PROCESSING COMPLETE |
| 29th Sep 2022 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| 15th Sep 2022 | USE AMENDMENT FILED |
| 15th Sep 2022 | TEAS STATEMENT OF USE RECEIVED |
| 29th Apr 2022 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 27th Apr 2022 | SOU EXTENSION 4 GRANTED |